On October 26, 2019, the bio-pharmaceutical innovation and development summit forum and the inaugurating of the industrial biotechnology industry transformation platform of Shandong Province was held in Lukang Bio-pharmaceutical Circular Economy Industrial Park, which indicated the first industrial biotechnology industry transformation platform of Shandong Province was established.
The industrial biotechnology industry transformation platform of Shandong Province is an open and shared industrial transformation platform jointly established by Tianjin Institute of Industrial Biotechnology of Chinese Academy of Sciences, Jining Municipal government and Lukang Pharma, approved by Shandong Province government on October 13, 2017. The construction area of the project is about 20,000 square meters, with four trial platforms including biotechnology, microorganism fermentation and extraction, chemical synthesis, enzyme preparation and probiotics, with quality control center. After two years of construction, the platform was completed and put into operation. At present, the platform has launched the R & D and transformation of innovative drug TRN-157, CIGB-814, phage lyase drug, trans-aconitine, Acuabio 4, amino acid and other products.